Danaher announces transition plan for chief financial officer

Washington , july 22, 2025 /prnewswire/ -- danaher corporation (nyse: dhr), a leading global life sciences and diagnostics innovator, today announced that matthew gugino, currently group chief financial officer of the company's life sciences innovations group and vice president of financial planning & analysis, will succeed matthew mcgrew as danaher's chief financial officer effective february 28 th, 2026. following the transition and consistent with past practice, mr.
DHR Ratings Summary
DHR Quant Ranking